Article

STAAR Surgical names Andrews as CFO

Monrovia, CA—STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.

Monrovia, CA-STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.

Andrews, who has been part of the firm's financial reporting team for more than 10 years, took on the role as CFO following the resignation of John Bily. She previously was the company's global controller.

In a prepared statement, company President and CEO David Bailey praised Andrews, 47, for improving STAAR's financial reporting and internal controls, and implementing cost-cutting strategies that reduced costs by $1.2 million during the second quarter of 2005 compared with the first quarter of 2005.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.